TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.49-CA$0.26 (-0.9%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.17% below the high.
Loading market information…
NASDAQ · HEXO · USD
Stock price, earnings
Quote as of Jun 22, 2023, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
HEXO Corp.’s quoted price sits in the lower half of its reported 52-week range, 81.49% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow HEXO Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
HEXO Corp. operates as a Canadian cannabis firm, utilizing its subsidiaries to cultivate, market, and distribute various cannabis products throughout the country. Its flagship HEXO brand caters to both the adult-use recreational and medicinal cannabis markets. Beyond its core offerings, the company provides a diverse range of cannabis-infused beverages, including popular labels such as Little Victory, House of Terpenes, Mollo, Veryvell, and XMG. Additionally, HEXO markets other cannabis products under distinct brands like UP Cannabis, Original Stash, and Up. The company has forged a significant strategic alliance with Tilray Brands, Inc. Founded in 2013, HEXO Corp. was originally known as The Hydropothecary Corporation before adopting its current name in August 2018. Its principal office is situated in Gatineau, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:28 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2022 | Dec 14, 2021 | -$1.26+10.0% vs estimate | $40.57M-16.57% vs estimate |
|---|
| Q4 2021 | Oct 29, 2021 | -$2.10-66.67% vs estimate | $98.98M+134.89% vs estimate |
|---|
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.49-CA$0.26 (-0.9%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.17% below the high.
CA$33.57-CA$0.10 (-0.3%)
Apotex Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.45% below the high.
CA$11.92-CA$0.21 (-1.73%)
Curaleaf Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 43.08% below the high.
$3.33-$0.03 (-0.89%)
Cronos Group Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.76% below the high.
$1.30-$0.01 (-0.38%)
SNDL Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.66% below the high.
$0.66-$0.02 (-2.22%)
Canopy Growth Corporation’s quoted price sits in the lower half of its reported 52-week range, 72.27% below the high.
$4.08-$0.01 (-0.12%)
Aurora Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.93% below the high.
$0.94-$0.02 (-2.39%)
Organigram Global Inc.’s quoted price sits in the lower half of its reported 52-week range, 58.15% below the high.
